CogniMS: observational study to assess cognition in patients with early Multiple Sclerosis - CogniMS
A long term follow up of relapsing remitting multiple sclerosis patients who have been treated with intereron beta -1b (Betaferon) at least 5 years
100 项与 Schering Oy 相关的临床结果
0 项与 Schering Oy 相关的专利(医药)
100 项与 Schering Oy 相关的药物交易
100 项与 Schering Oy 相关的转化医学